 |
 |

Attitudes Toward Antipsychotic Medication
The Impact of Clinical Variables and Relationships With Health Professionals
Jennifer C. Day, PhD;
Richard P. Bentall, PhD;
Chris Roberts, PhD;
Fiona Randall, BSc;
Anne Rogers, PhD;
Dinah Cattell, RMN;
David Healy, MD;
Pam Rae, BSc;
Cheryl Power, MSc
Arch Gen Psychiatry. 2005;62:717-724.
Context Nonadherence to antipsychotic medication is a major cause of psychotic relapse and is strongly influenced by attitudes toward treatment. Although patient variables such as insight and symptoms that contribute toward attitudes have been identified, the contributions of relationship and service factors have not been adequately studied.
Objective To determine relations between clinical and service variables and attitudes toward medication in people with a diagnosis of schizophrenia and schizoaffective disorder.
Design Consecutively admitted patients were approached to take part; 23 refused. Measures included symptoms, insight, drug adverse effects, self-reported adherence, attitudes toward treatment, perceived relationship with the prescriber, ward atmosphere, and admission experience. Data were analyzed by a proportional odds model and structural equation modeling to test predicted paths between experience of admission, relationship variables, attitudes toward treatment, and self-reported adherence to medication.
Setting Twenty-eight inpatient wards at 8 hospitals in North Wales and the Northwest of England. Sites included hospitals with inner-city and rural catchment areas.
Patients Two hundred twenty-eight patients meeting DSM-IV criteria for schizophrenia or schizoaffective disorder, assessed during acute admission.
Main Outcome Measures Attitudes toward treatment and self-reported adherence to medication.
Results The data fit a model in which attitudes toward treatment were predicted by insight, relationship with staff (especially the physician-prescriber), and the patients admission experience (maximum likelihood 249 = 89.3, P<.001). A poor relationship with the prescriber, experience of coercion during admission, and low insight predicted a negative attitude toward treatment.
Conclusions The quality of relationships with clinicians during acute admission appears to be an important determinant of patients attitudes toward treatment and adherence to medication. Enhancing such relationships may yield important clinical benefits.
Author Affiliations: Pharmacy Department, Mersey Care NHS Trust, Merseyside, England (Dr Day); School of Pharmacy and Chemistry, Liverpool John Moores University, Liverpool, England (Dr Day); Department of Psychology (Dr Bentall), Biostatistics Group, School of Epidemiology and Health Sciences (Dr Roberts), and National Primary Care Research and Development Centre (Dr Rogers), University of Manchester, Manchester, England; North Wales Clinical Psychology Department, University of Wales, Bangor (Ms Randall); Division of Psychological Medicine, North Wales Department, Wales College of Medicine, Cardiff University, Cardiff (Ms Cattell and Dr Healy); and Department of Clinical Psychology, University of Liverpool, Liverpool (Mss Rae and Power).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Efficacy and Tolerability of Second-Generation Antipsychotics in Children and Adolescents With Schizophrenia
Kumra et al.
Schizophr Bull 2008;34:60-71.
ABSTRACT
| FULL TEXT
Correlates and Long-Term Consequences of Poor Insight in Patients With Schizophrenia. A Systematic Review
Lincoln et al.
Schizophr Bull 2007;33:1324-1342.
ABSTRACT
| FULL TEXT
Patient-reported outcomes in schizophrenia
McCabe et al.
Br. J. Psychiatry 2007;191:s21-s28.
ABSTRACT
| FULL TEXT
Understanding and Preventing Criminal Recidivism Among Adults With Psychotic Disorders
Lamberti
Psychiatr. Serv. 2007;58:773-781.
ABSTRACT
| FULL TEXT
Differential Medication Adherence Among Patients With Schizophrenia and Comorbid Diabetes and Hypertension
Piette et al.
Psychiatr. Serv. 2007;58:207-212.
ABSTRACT
| FULL TEXT
Helping patients with paranoid and suspicious thoughts: a cognitive-behavioural approach
Freeman and Garety
Adv. Psychiatr. Treat. 2006;12:404-415.
ABSTRACT
| FULL TEXT
Defining and Assessing Adherence to Oral Antipsychotics: A Review of the Literature
Velligan et al.
Schizophr Bull 2006;32:724-742.
ABSTRACT
| FULL TEXT
Recent Advances in Social Skills Training for Schizophrenia
Kopelowicz et al.
Schizophr Bull 2006;32:S12-S23.
ABSTRACT
| FULL TEXT
The Illness Management and Recovery Program: Rationale, Development, and Preliminary Findings
Mueser et al.
Schizophr Bull 2006;32:S32-S43.
ABSTRACT
| FULL TEXT
|